The Board
Jag Grewal
BSc (Hons), MSc, MBA
Chief Executive Officer
Carolyn Rand
FCMA, FCMI, CGMA, Cert IoD
Non-Executive Chair
Jeremy Millard
BA (Hons), MEng
Non-Executive Director
Jag Grewal, BSc (Hons), MSc, MBA
Chief Executive Officer
appointed on 30 June 2011
Jag joined Cambridge Nutritional Sciences in June 2011 as Group Sales and Marketing Director. He has worked in the medical diagnostics industry for over 25 years having started out as a Clinical Biochemist in the NHS. In 1995 he joined Beckman Instruments where he developed a career spanning 15 years in sales and marketing holding a variety of positions in sales, product management and marketing management. In 2009 he left his position of Northern Europe Marketing Manager to join Serco Health, where he helped create the first joint venture within UK pathology between Serco and Guy’s and St Thomas’ Hospital. He is also past Chairman and current Treasurer of the British In Vitro Diagnostics Association (BIVDA).
Jag was appointed as CEO in January 2022. Prior to this appointment, Jag was responsible for managing the Health and Nutrition division.
Carolyn Rand, FCMA, FCMI, CGMA, Cert IoD
Non-Executive Chair
appointed on 17 August 2023
Carolyn is a professional Non-Executive Director with over 30 years’ experience across public and private enterprises. Her current responsibilities include Non-Executive Director and Audit Committee Chair of AIM-quoted global technology businesses, IQGeo plc and PCI Pal plc and as a Governor of the University Collage of West Anglia. She is a Fellow of the Chartered Institute of Management Accountants having served as Regional Chair for over eight years. In addition she served as Chair for the Institute of Directors for Cambridgeshire.
Other prior directorships include Strategic Advisor for AIM-quoted global technology business Bango plc where she previously held the office of CFO.
Throughout her career, Carolyn held executive positions within high-growth Biotechnology and technology businesses including, CEO of Isogenica and CFO of Zinwave.
Jeremy Millard, BA (Hons), MEng
Non-Executive Director
appointed on 1 March 2019
Chairman of the Audit Committee and member of the Remuneration Committee.
Jeremy has 20 years’ investment banking experience and was previously a Partner at Smith Square Partners LLP where he provided strategic and corporate finance advice to clients in the science, technology and telecommunications sectors, prior to which he headed up the technology practice at Rothschild in London. Jeremy runs corporate finance business Iridium Corporate Finance and is also currently a Non-Executive Director and Chairman of the Audit Committee of AIM-listed Ilika plc as well as sitting on the boards of a number of other private UK companies.
Latest Share Price
Investor News
-
22 April 2024
Trading Update and Directorate Change -
03 April 2024
Q2 2024 Industry Events Schedule